Addus HomeCare (NASDAQ:ADUS): Q2 Non-GAAP EPS of $0.56 beats by $0.03; GAAP EPS of $0.41 misses by $0.07.
Revenue of $149.69M (+14.0% Y/Y) beats by $3.69M.
Shares +1.36%.
Monday, August 5, 2019
China Biologic Products EPS beats by $0.21
China Biologic Products (NASDAQ:CBPO): Q2 Non-GAAP EPS of $1.24 beats by $0.21; GAAP EPS of $1.06.
Revenue of $135.7M (+12.7% Y/Y)
Tenet Q2 beats expectations; guidance maintained
Tenet Healthcare (NYSE:THC) Q2 results ($M): Revenues: 4,560 (+1.2%).
Net income: (15) (-37.5%); EPS: 0.14 (-39.1%); non-GAAP EBITDA: 657 (+3.6%).
Q3 guidance: Revenue: $4.3B – 4.6B; net income: ($16M) – 21M; non-GAAP EBITDA: $600M – 650M; EPS: ($0.15) – 0.20; non-GAAP EPS: $0.23 – 0.48.
2019 guidance: Revenue: $18.0B – 18.4B (unch); net income: $16M – 116M from $17M – 115M; non-GAAP EBITDA: $2.65B – 2.75B (unch); EPS: $0.15 – 1.09 from $0.16 – 1.10; non-GAAP EPS: $2.08 – 2.59 (unch); cash flow ops: $1.070B – 1.375B (unch).
Previously: Tenet Healthcare EPS beats by $0.12, beats on revenue (Aug. 5)
Assembly Biosciences EPS beats by $0.43, misses on revenue
Assembly Biosciences (NASDAQ:ASMB): Q2 GAAP EPS of -$0.72 beats by $0.43.
Revenue of $3.08M (-4.3% Y/Y) misses by $0.64M.
Harpoon Therapeutics EPS beats by $0.16, misses on revenue
Harpoon Therapeutics (NASDAQ:HARP): Q2 GAAP EPS of -$0.49 beats by $0.16.
Revenue of $1.06M (flat Y/Y) misses by $0.13M.
Mirati Therapeutics reports Q2 results
Mirati Therapeutics (NASDAQ:MRTX): Q2 GAAP EPS of -$1.26.
Revenue of $0.58M
Cash, cash equivalents, and short-term investments of $485.5M
ShockWave Medical EPS beats by $0.14, beats on revenue
ShockWave Medical (NASDAQ:SWAV): Q2 GAAP EPS of -$0.38 beats by $0.14.
Revenue of $10.01M (+339.0% Y/Y) beats by $1.72M.
Subscribe to:
Posts (Atom)